nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CALM1—Alzheimer's disease	0.184	0.415	CbGaD
Perphenazine—HTR6—Alzheimer's disease	0.166	0.374	CbGaD
Perphenazine—HTR2A—Donepezil—Alzheimer's disease	0.0664	0.212	CbGbCtD
Perphenazine—DRD2—Memantine—Alzheimer's disease	0.053	0.169	CbGbCtD
Perphenazine—HTR2A—Alzheimer's disease	0.0489	0.11	CbGaD
Perphenazine—CYP2D6—Alzheimer's disease	0.0447	0.101	CbGaD
Perphenazine—CYP2B6—Memantine—Alzheimer's disease	0.0396	0.127	CbGbCtD
Perphenazine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0276	0.0882	CbGbCtD
Perphenazine—CYP2C19—Memantine—Alzheimer's disease	0.0252	0.0804	CbGbCtD
Perphenazine—CYP2C9—Donepezil—Alzheimer's disease	0.0242	0.0771	CbGbCtD
Perphenazine—CYP2D6—Donepezil—Alzheimer's disease	0.0221	0.0705	CbGbCtD
Perphenazine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0176	0.0561	CbGbCtD
Perphenazine—CYP2D6—Galantamine—Alzheimer's disease	0.0142	0.0454	CbGbCtD
Perphenazine—CYP3A4—Donepezil—Alzheimer's disease	0.014	0.0448	CbGbCtD
Perphenazine—CYP3A4—Galantamine—Alzheimer's disease	0.00905	0.0289	CbGbCtD
Perphenazine—Neurogenic bladder—Rivastigmine—Alzheimer's disease	0.00814	0.0885	CcSEcCtD
Perphenazine—HTR2C—choroid plexus—Alzheimer's disease	0.00648	0.126	CbGeAlD
Perphenazine—HTR2A—choroid plexus—Alzheimer's disease	0.00325	0.0632	CbGeAlD
Perphenazine—HTR7—locus ceruleus—Alzheimer's disease	0.00322	0.0626	CbGeAlD
Perphenazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00244	0.0475	CbGeAlD
Perphenazine—Incontinence—Galantamine—Alzheimer's disease	0.00244	0.0265	CcSEcCtD
Perphenazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00201	0.039	CbGeAlD
Perphenazine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.0019	0.0369	CbGeAlD
Perphenazine—Retinal disorder—Rivastigmine—Alzheimer's disease	0.00164	0.0178	CcSEcCtD
Perphenazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00164	0.0318	CbGeAlD
Perphenazine—Tardive dyskinesia—Memantine—Alzheimer's disease	0.00161	0.0175	CcSEcCtD
Perphenazine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.0016	0.0311	CbGeAlD
Perphenazine—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.00157	0.0171	CcSEcCtD
Perphenazine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00153	0.0297	CbGeAlD
Perphenazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00144	0.0281	CbGeAlD
Perphenazine—Parkinsonism—Memantine—Alzheimer's disease	0.00132	0.0143	CcSEcCtD
Perphenazine—Parkinsonism—Rivastigmine—Alzheimer's disease	0.00129	0.014	CcSEcCtD
Perphenazine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00129	0.014	CcSEcCtD
Perphenazine—Hyperreflexia—Rivastigmine—Alzheimer's disease	0.00127	0.0138	CcSEcCtD
Perphenazine—Sudden death—Memantine—Alzheimer's disease	0.00117	0.0127	CcSEcCtD
Perphenazine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00117	0.0127	CcSEcCtD
Perphenazine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00113	0.0123	CcSEcCtD
Perphenazine—Inappropriate antidiuretic hormone secretion—Memantine—Alzheimer's disease	0.00103	0.0112	CcSEcCtD
Perphenazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000952	0.0185	CbGeAlD
Perphenazine—Throat sore—Donepezil—Alzheimer's disease	0.000915	0.00995	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.000907	0.00987	CcSEcCtD
Perphenazine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.000876	0.00953	CcSEcCtD
Perphenazine—Glaucoma—Donepezil—Alzheimer's disease	0.000876	0.00953	CcSEcCtD
Perphenazine—HTR6—forebrain—Alzheimer's disease	0.000858	0.0167	CbGeAlD
Perphenazine—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.000827	0.00899	CcSEcCtD
Perphenazine—Glycosuria—Donepezil—Alzheimer's disease	0.000814	0.00886	CcSEcCtD
Perphenazine—Glaucoma—Memantine—Alzheimer's disease	0.000795	0.00865	CcSEcCtD
Perphenazine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000795	0.00865	CcSEcCtD
Perphenazine—HTR6—telencephalon—Alzheimer's disease	0.000789	0.0153	CbGeAlD
Perphenazine—Glaucoma—Rivastigmine—Alzheimer's disease	0.000778	0.00846	CcSEcCtD
Perphenazine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.000778	0.00846	CcSEcCtD
Perphenazine—CALM2—blood vessel—Alzheimer's disease	0.000777	0.0151	CbGeAlD
Perphenazine—CALM1—blood vessel—Alzheimer's disease	0.000773	0.015	CbGeAlD
Perphenazine—HTR7—blood vessel—Alzheimer's disease	0.000756	0.0147	CbGeAlD
Perphenazine—Hyperkinesia—Galantamine—Alzheimer's disease	0.000742	0.00807	CcSEcCtD
Perphenazine—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.000725	0.00789	CcSEcCtD
Perphenazine—Pallor—Memantine—Alzheimer's disease	0.000723	0.00786	CcSEcCtD
Perphenazine—Pallor—Rivastigmine—Alzheimer's disease	0.000707	0.00769	CcSEcCtD
Perphenazine—Dysarthria—Donepezil—Alzheimer's disease	0.000697	0.00759	CcSEcCtD
Perphenazine—Abnormal dreams—Donepezil—Alzheimer's disease	0.000652	0.00709	CcSEcCtD
Perphenazine—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000641	0.00697	CcSEcCtD
Perphenazine—DRD1—forebrain—Alzheimer's disease	0.000638	0.0124	CbGeAlD
Perphenazine—Dyskinesia—Memantine—Alzheimer's disease	0.000637	0.00693	CcSEcCtD
Perphenazine—Lethargy—Galantamine—Alzheimer's disease	0.000631	0.00686	CcSEcCtD
Perphenazine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000624	0.00678	CcSEcCtD
Perphenazine—Dysarthria—Rivastigmine—Alzheimer's disease	0.00062	0.00674	CcSEcCtD
Perphenazine—Urinary retention—Galantamine—Alzheimer's disease	0.000588	0.00639	CcSEcCtD
Perphenazine—DRD1—telencephalon—Alzheimer's disease	0.000587	0.0114	CbGeAlD
Perphenazine—Ataxia—Galantamine—Alzheimer's disease	0.000581	0.00632	CcSEcCtD
Perphenazine—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.000579	0.0063	CcSEcCtD
Perphenazine—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000569	0.00619	CcSEcCtD
Perphenazine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000564	0.00614	CcSEcCtD
Perphenazine—Muscular weakness—Galantamine—Alzheimer's disease	0.000545	0.00593	CcSEcCtD
Perphenazine—Urine output increased—Memantine—Alzheimer's disease	0.000542	0.00589	CcSEcCtD
Perphenazine—Dysphagia—Galantamine—Alzheimer's disease	0.000534	0.00581	CcSEcCtD
Perphenazine—Eczema—Donepezil—Alzheimer's disease	0.000533	0.0058	CcSEcCtD
Perphenazine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00053	0.00577	CcSEcCtD
Perphenazine—Urine output increased—Rivastigmine—Alzheimer's disease	0.00053	0.00576	CcSEcCtD
Perphenazine—Hyperkinesia—Memantine—Alzheimer's disease	0.000522	0.00568	CcSEcCtD
Perphenazine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000511	0.00556	CcSEcCtD
Perphenazine—HTR2C—forebrain—Alzheimer's disease	0.000496	0.00964	CbGeAlD
Perphenazine—Polyuria—Memantine—Alzheimer's disease	0.000495	0.00539	CcSEcCtD
Perphenazine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.000491	0.00534	CcSEcCtD
Perphenazine—Polyuria—Rivastigmine—Alzheimer's disease	0.000484	0.00527	CcSEcCtD
Perphenazine—Eczema—Memantine—Alzheimer's disease	0.000484	0.00526	CcSEcCtD
Perphenazine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000482	0.00524	CcSEcCtD
Perphenazine—CALM3—telencephalon—Alzheimer's disease	0.00048	0.00934	CbGeAlD
Perphenazine—Eczema—Rivastigmine—Alzheimer's disease	0.000473	0.00515	CcSEcCtD
Perphenazine—HTR2A—blood vessel—Alzheimer's disease	0.000471	0.00916	CbGeAlD
Perphenazine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000468	0.00509	CcSEcCtD
Perphenazine—HTR6—nervous system—Alzheimer's disease	0.000466	0.00905	CbGeAlD
Perphenazine—CALM2—embryo—Alzheimer's disease	0.000464	0.00902	CbGeAlD
Perphenazine—CALM1—embryo—Alzheimer's disease	0.000461	0.00897	CbGeAlD
Perphenazine—HTR2C—telencephalon—Alzheimer's disease	0.000456	0.00886	CbGeAlD
Perphenazine—Urinary retention—Donepezil—Alzheimer's disease	0.000455	0.00495	CcSEcCtD
Perphenazine—Ataxia—Donepezil—Alzheimer's disease	0.00045	0.0049	CcSEcCtD
Perphenazine—HTR6—central nervous system—Alzheimer's disease	0.000448	0.00872	CbGeAlD
Perphenazine—Hypoglycaemia—Memantine—Alzheimer's disease	0.000446	0.00485	CcSEcCtD
Perphenazine—Lethargy—Memantine—Alzheimer's disease	0.000444	0.00483	CcSEcCtD
Perphenazine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000437	0.00476	CcSEcCtD
Perphenazine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000436	0.00474	CcSEcCtD
Perphenazine—Bradycardia—Galantamine—Alzheimer's disease	0.000435	0.00473	CcSEcCtD
Perphenazine—Psychotic disorder—Memantine—Alzheimer's disease	0.000425	0.00462	CcSEcCtD
Perphenazine—Muscular weakness—Donepezil—Alzheimer's disease	0.000422	0.00459	CcSEcCtD
Perphenazine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000421	0.00458	CcSEcCtD
Perphenazine—HTR1A—forebrain—Alzheimer's disease	0.000417	0.00811	CbGeAlD
Perphenazine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000415	0.00452	CcSEcCtD
Perphenazine—Dysphagia—Donepezil—Alzheimer's disease	0.000414	0.0045	CcSEcCtD
Perphenazine—Asthma—Donepezil—Alzheimer's disease	0.000414	0.0045	CcSEcCtD
Perphenazine—Cardiac arrest—Memantine—Alzheimer's disease	0.000413	0.0045	CcSEcCtD
Perphenazine—Urinary retention—Memantine—Alzheimer's disease	0.000413	0.0045	CcSEcCtD
Perphenazine—CALM2—forebrain—Alzheimer's disease	0.00041	0.00797	CbGeAlD
Perphenazine—Eosinophilia—Donepezil—Alzheimer's disease	0.00041	0.00446	CcSEcCtD
Perphenazine—Ataxia—Memantine—Alzheimer's disease	0.000409	0.00445	CcSEcCtD
Perphenazine—CALM1—forebrain—Alzheimer's disease	0.000408	0.00794	CbGeAlD
Perphenazine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000404	0.0044	CcSEcCtD
Perphenazine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000404	0.0044	CcSEcCtD
Perphenazine—Ataxia—Rivastigmine—Alzheimer's disease	0.0004	0.00435	CcSEcCtD
Perphenazine—HTR7—forebrain—Alzheimer's disease	0.000399	0.00775	CbGeAlD
Perphenazine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000397	0.00432	CcSEcCtD
Perphenazine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000389	0.00423	CcSEcCtD
Perphenazine—HTR1A—telencephalon—Alzheimer's disease	0.000384	0.00746	CbGeAlD
Perphenazine—Muscular weakness—Memantine—Alzheimer's disease	0.000383	0.00417	CcSEcCtD
Perphenazine—CALM2—telencephalon—Alzheimer's disease	0.000377	0.00733	CbGeAlD
Perphenazine—DRD2—forebrain—Alzheimer's disease	0.000377	0.00733	CbGeAlD
Perphenazine—Asthma—Memantine—Alzheimer's disease	0.000376	0.00409	CcSEcCtD
Perphenazine—Dysphagia—Memantine—Alzheimer's disease	0.000376	0.00409	CcSEcCtD
Perphenazine—CALM1—telencephalon—Alzheimer's disease	0.000375	0.0073	CbGeAlD
Perphenazine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000375	0.00408	CcSEcCtD
Perphenazine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000373	0.00406	CcSEcCtD
Perphenazine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000368	0.004	CcSEcCtD
Perphenazine—HTR7—telencephalon—Alzheimer's disease	0.000367	0.00713	CbGeAlD
Perphenazine—Jaundice—Donepezil—Alzheimer's disease	0.00036	0.00391	CcSEcCtD
Perphenazine—Muscle spasms—Galantamine—Alzheimer's disease	0.000358	0.00389	CcSEcCtD
Perphenazine—Pancytopenia—Memantine—Alzheimer's disease	0.000357	0.00388	CcSEcCtD
Perphenazine—HTR6—brain—Alzheimer's disease	0.000356	0.00692	CbGeAlD
Perphenazine—Vision blurred—Galantamine—Alzheimer's disease	0.000351	0.00381	CcSEcCtD
Perphenazine—DRD2—telencephalon—Alzheimer's disease	0.000347	0.00674	CbGeAlD
Perphenazine—DRD1—nervous system—Alzheimer's disease	0.000346	0.00674	CbGeAlD
Perphenazine—Agitation—Galantamine—Alzheimer's disease	0.000342	0.00372	CcSEcCtD
Perphenazine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000339	0.00369	CcSEcCtD
Perphenazine—Bradycardia—Donepezil—Alzheimer's disease	0.000337	0.00367	CcSEcCtD
Perphenazine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000336	0.00365	CcSEcCtD
Perphenazine—Syncope—Galantamine—Alzheimer's disease	0.000334	0.00363	CcSEcCtD
Perphenazine—DRD1—central nervous system—Alzheimer's disease	0.000333	0.00648	CbGeAlD
Perphenazine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000332	0.00361	CcSEcCtD
Perphenazine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00033	0.00359	CcSEcCtD
Perphenazine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000328	0.00357	CcSEcCtD
Perphenazine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000327	0.00356	CcSEcCtD
Perphenazine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000326	0.00355	CcSEcCtD
Perphenazine—Cough—Galantamine—Alzheimer's disease	0.000325	0.00353	CcSEcCtD
Perphenazine—Convulsion—Galantamine—Alzheimer's disease	0.000322	0.00351	CcSEcCtD
Perphenazine—Hypertension—Galantamine—Alzheimer's disease	0.000321	0.00349	CcSEcCtD
Perphenazine—Agranulocytosis—Memantine—Alzheimer's disease	0.000313	0.0034	CcSEcCtD
Perphenazine—Dry mouth—Galantamine—Alzheimer's disease	0.00031	0.00337	CcSEcCtD
Perphenazine—Confusional state—Galantamine—Alzheimer's disease	0.000306	0.00333	CcSEcCtD
Perphenazine—Bradycardia—Memantine—Alzheimer's disease	0.000306	0.00333	CcSEcCtD
Perphenazine—Bradycardia—Rivastigmine—Alzheimer's disease	0.0003	0.00326	CcSEcCtD
Perphenazine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000299	0.00326	CcSEcCtD
Perphenazine—Shock—Galantamine—Alzheimer's disease	0.000299	0.00325	CcSEcCtD
Perphenazine—HRH1—forebrain—Alzheimer's disease	0.000298	0.00579	CbGeAlD
Perphenazine—Tachycardia—Galantamine—Alzheimer's disease	0.000296	0.00322	CcSEcCtD
Perphenazine—Oedema peripheral—Memantine—Alzheimer's disease	0.000296	0.00322	CcSEcCtD
Perphenazine—AOX1—cerebellum—Alzheimer's disease	0.000296	0.00576	CbGeAlD
Perphenazine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000293	0.00318	CcSEcCtD
Perphenazine—ADRA2A—forebrain—Alzheimer's disease	0.000292	0.00569	CbGeAlD
Perphenazine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00029	0.00315	CcSEcCtD
Perphenazine—Anorexia—Galantamine—Alzheimer's disease	0.000289	0.00315	CcSEcCtD
Perphenazine—Erythema—Donepezil—Alzheimer's disease	0.000288	0.00314	CcSEcCtD
Perphenazine—Hypotension—Galantamine—Alzheimer's disease	0.000284	0.00309	CcSEcCtD
Perphenazine—HTR2A—embryo—Alzheimer's disease	0.000281	0.00547	CbGeAlD
Perphenazine—Muscle spasms—Donepezil—Alzheimer's disease	0.000277	0.00302	CcSEcCtD
Perphenazine—Insomnia—Galantamine—Alzheimer's disease	0.000275	0.00299	CcSEcCtD
Perphenazine—HRH1—telencephalon—Alzheimer's disease	0.000274	0.00532	CbGeAlD
Perphenazine—Vision blurred—Donepezil—Alzheimer's disease	0.000272	0.00296	CcSEcCtD
Perphenazine—Somnolence—Galantamine—Alzheimer's disease	0.00027	0.00294	CcSEcCtD
Perphenazine—HTR2C—nervous system—Alzheimer's disease	0.000269	0.00523	CbGeAlD
Perphenazine—ADRA2A—telencephalon—Alzheimer's disease	0.000269	0.00523	CbGeAlD
Perphenazine—CALM3—cerebellum—Alzheimer's disease	0.000267	0.00519	CbGeAlD
Perphenazine—Agitation—Donepezil—Alzheimer's disease	0.000265	0.00288	CcSEcCtD
Perphenazine—DRD1—brain—Alzheimer's disease	0.000265	0.00515	CbGeAlD
Perphenazine—Decreased appetite—Galantamine—Alzheimer's disease	0.000264	0.00287	CcSEcCtD
Perphenazine—Constipation—Galantamine—Alzheimer's disease	0.00026	0.00282	CcSEcCtD
Perphenazine—HTR2C—central nervous system—Alzheimer's disease	0.000259	0.00504	CbGeAlD
Perphenazine—Syncope—Donepezil—Alzheimer's disease	0.000259	0.00281	CcSEcCtD
Perphenazine—Erythema—Rivastigmine—Alzheimer's disease	0.000256	0.00279	CcSEcCtD
Perphenazine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000253	0.00276	CcSEcCtD
Perphenazine—Cough—Donepezil—Alzheimer's disease	0.000252	0.00274	CcSEcCtD
Perphenazine—Convulsion—Donepezil—Alzheimer's disease	0.00025	0.00272	CcSEcCtD
Perphenazine—Hypertension—Donepezil—Alzheimer's disease	0.000249	0.00271	CcSEcCtD
Perphenazine—HTR2A—forebrain—Alzheimer's disease	0.000249	0.00483	CbGeAlD
Perphenazine—Vision blurred—Memantine—Alzheimer's disease	0.000247	0.00268	CcSEcCtD
Perphenazine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000246	0.00268	CcSEcCtD
Perphenazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000241	0.00263	CcSEcCtD
Perphenazine—Agitation—Memantine—Alzheimer's disease	0.000241	0.00262	CcSEcCtD
Perphenazine—AOX1—brain—Alzheimer's disease	0.000241	0.00468	CbGeAlD
Perphenazine—Dry mouth—Donepezil—Alzheimer's disease	0.00024	0.00261	CcSEcCtD
Perphenazine—Body temperature increased—Galantamine—Alzheimer's disease	0.00024	0.00261	CcSEcCtD
Perphenazine—Confusional state—Donepezil—Alzheimer's disease	0.000237	0.00258	CcSEcCtD
Perphenazine—Agitation—Rivastigmine—Alzheimer's disease	0.000235	0.00256	CcSEcCtD
Perphenazine—Syncope—Memantine—Alzheimer's disease	0.000235	0.00255	CcSEcCtD
Perphenazine—Leukopenia—Memantine—Alzheimer's disease	0.000234	0.00255	CcSEcCtD
Perphenazine—Infection—Donepezil—Alzheimer's disease	0.000234	0.00254	CcSEcCtD
Perphenazine—Shock—Donepezil—Alzheimer's disease	0.000232	0.00252	CcSEcCtD
Perphenazine—Loss of consciousness—Memantine—Alzheimer's disease	0.00023	0.0025	CcSEcCtD
Perphenazine—Syncope—Rivastigmine—Alzheimer's disease	0.00023	0.0025	CcSEcCtD
Perphenazine—HTR2A—telencephalon—Alzheimer's disease	0.000229	0.00445	CbGeAlD
Perphenazine—Cough—Memantine—Alzheimer's disease	0.000228	0.00249	CcSEcCtD
Perphenazine—Convulsion—Memantine—Alzheimer's disease	0.000227	0.00247	CcSEcCtD
Perphenazine—CYP2D6—forebrain—Alzheimer's disease	0.000226	0.0044	CbGeAlD
Perphenazine—HTR1A—nervous system—Alzheimer's disease	0.000226	0.0044	CbGeAlD
Perphenazine—Hypertension—Memantine—Alzheimer's disease	0.000226	0.00246	CcSEcCtD
Perphenazine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000225	0.00245	CcSEcCtD
Perphenazine—Anorexia—Donepezil—Alzheimer's disease	0.000224	0.00244	CcSEcCtD
Perphenazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000224	0.00243	CcSEcCtD
Perphenazine—Cough—Rivastigmine—Alzheimer's disease	0.000224	0.00243	CcSEcCtD
Perphenazine—CALM2—nervous system—Alzheimer's disease	0.000223	0.00433	CbGeAlD
Perphenazine—Convulsion—Rivastigmine—Alzheimer's disease	0.000222	0.00241	CcSEcCtD
Perphenazine—CALM1—nervous system—Alzheimer's disease	0.000222	0.00431	CbGeAlD
Perphenazine—Hypertension—Rivastigmine—Alzheimer's disease	0.000221	0.00241	CcSEcCtD
Perphenazine—Hypotension—Donepezil—Alzheimer's disease	0.00022	0.00239	CcSEcCtD
Perphenazine—Dry mouth—Memantine—Alzheimer's disease	0.000218	0.00237	CcSEcCtD
Perphenazine—HTR1A—central nervous system—Alzheimer's disease	0.000218	0.00424	CbGeAlD
Perphenazine—CALM3—brain—Alzheimer's disease	0.000217	0.00421	CbGeAlD
Perphenazine—HTR7—nervous system—Alzheimer's disease	0.000216	0.00421	CbGeAlD
Perphenazine—Confusional state—Memantine—Alzheimer's disease	0.000215	0.00234	CcSEcCtD
Perphenazine—CALM2—central nervous system—Alzheimer's disease	0.000214	0.00417	CbGeAlD
Perphenazine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000213	0.00232	CcSEcCtD
Perphenazine—CALM1—central nervous system—Alzheimer's disease	0.000213	0.00415	CbGeAlD
Perphenazine—HTR1A—cerebellum—Alzheimer's disease	0.000213	0.00414	CbGeAlD
Perphenazine—Insomnia—Donepezil—Alzheimer's disease	0.000213	0.00232	CcSEcCtD
Perphenazine—Infection—Memantine—Alzheimer's disease	0.000212	0.00231	CcSEcCtD
Perphenazine—Confusional state—Rivastigmine—Alzheimer's disease	0.000211	0.00229	CcSEcCtD
Perphenazine—Shock—Memantine—Alzheimer's disease	0.00021	0.00229	CcSEcCtD
Perphenazine—Dyspnoea—Donepezil—Alzheimer's disease	0.00021	0.00228	CcSEcCtD
Perphenazine—CALM2—cerebellum—Alzheimer's disease	0.000209	0.00407	CbGeAlD
Perphenazine—Somnolence—Donepezil—Alzheimer's disease	0.000209	0.00228	CcSEcCtD
Perphenazine—Tachycardia—Memantine—Alzheimer's disease	0.000209	0.00227	CcSEcCtD
Perphenazine—CALM1—cerebellum—Alzheimer's disease	0.000208	0.00405	CbGeAlD
Perphenazine—HTR7—central nervous system—Alzheimer's disease	0.000208	0.00405	CbGeAlD
Perphenazine—CYP2D6—telencephalon—Alzheimer's disease	0.000208	0.00405	CbGeAlD
Perphenazine—Diarrhoea—Galantamine—Alzheimer's disease	0.000208	0.00226	CcSEcCtD
Perphenazine—Infection—Rivastigmine—Alzheimer's disease	0.000208	0.00226	CcSEcCtD
Perphenazine—Shock—Rivastigmine—Alzheimer's disease	0.000206	0.00224	CcSEcCtD
Perphenazine—HTR2C—brain—Alzheimer's disease	0.000206	0.004	CbGeAlD
Perphenazine—Decreased appetite—Donepezil—Alzheimer's disease	0.000205	0.00223	CcSEcCtD
Perphenazine—DRD2—nervous system—Alzheimer's disease	0.000205	0.00398	CbGeAlD
Perphenazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000204	0.00222	CcSEcCtD
Perphenazine—Anorexia—Memantine—Alzheimer's disease	0.000204	0.00222	CcSEcCtD
Perphenazine—HTR7—cerebellum—Alzheimer's disease	0.000204	0.00396	CbGeAlD
Perphenazine—Pain—Donepezil—Alzheimer's disease	0.000201	0.00219	CcSEcCtD
Perphenazine—Constipation—Donepezil—Alzheimer's disease	0.000201	0.00219	CcSEcCtD
Perphenazine—Dizziness—Galantamine—Alzheimer's disease	0.000201	0.00218	CcSEcCtD
Perphenazine—Hypotension—Memantine—Alzheimer's disease	0.0002	0.00217	CcSEcCtD
Perphenazine—Anorexia—Rivastigmine—Alzheimer's disease	0.000199	0.00217	CcSEcCtD
Perphenazine—DRD2—central nervous system—Alzheimer's disease	0.000197	0.00383	CbGeAlD
Perphenazine—Hypotension—Rivastigmine—Alzheimer's disease	0.000195	0.00212	CcSEcCtD
Perphenazine—Insomnia—Memantine—Alzheimer's disease	0.000193	0.0021	CcSEcCtD
Perphenazine—DRD2—cerebellum—Alzheimer's disease	0.000193	0.00374	CbGeAlD
Perphenazine—Dyspnoea—Memantine—Alzheimer's disease	0.000191	0.00207	CcSEcCtD
Perphenazine—Headache—Galantamine—Alzheimer's disease	0.00019	0.00207	CcSEcCtD
Perphenazine—Somnolence—Memantine—Alzheimer's disease	0.00019	0.00207	CcSEcCtD
Perphenazine—Insomnia—Rivastigmine—Alzheimer's disease	0.000189	0.00206	CcSEcCtD
Perphenazine—Urticaria—Donepezil—Alzheimer's disease	0.000187	0.00203	CcSEcCtD
Perphenazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000186	0.00203	CcSEcCtD
Perphenazine—Body temperature increased—Donepezil—Alzheimer's disease	0.000186	0.00202	CcSEcCtD
Perphenazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000186	0.00202	CcSEcCtD
Perphenazine—Decreased appetite—Memantine—Alzheimer's disease	0.000186	0.00202	CcSEcCtD
Perphenazine—Pain—Memantine—Alzheimer's disease	0.000183	0.00199	CcSEcCtD
Perphenazine—Constipation—Memantine—Alzheimer's disease	0.000183	0.00199	CcSEcCtD
Perphenazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000182	0.00198	CcSEcCtD
Perphenazine—Constipation—Rivastigmine—Alzheimer's disease	0.000179	0.00194	CcSEcCtD
Perphenazine—Pain—Rivastigmine—Alzheimer's disease	0.000179	0.00194	CcSEcCtD
Perphenazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000173	0.00189	CcSEcCtD
Perphenazine—HTR1A—brain—Alzheimer's disease	0.000173	0.00337	CbGeAlD
Perphenazine—CALM2—brain—Alzheimer's disease	0.00017	0.00331	CbGeAlD
Perphenazine—Urticaria—Memantine—Alzheimer's disease	0.00017	0.00185	CcSEcCtD
Perphenazine—CALM1—brain—Alzheimer's disease	0.000169	0.00329	CbGeAlD
Perphenazine—Body temperature increased—Memantine—Alzheimer's disease	0.000169	0.00184	CcSEcCtD
Perphenazine—Pruritus—Donepezil—Alzheimer's disease	0.000167	0.00181	CcSEcCtD
Perphenazine—Urticaria—Rivastigmine—Alzheimer's disease	0.000166	0.00181	CcSEcCtD
Perphenazine—CYP2B6—nervous system—Alzheimer's disease	0.000165	0.00322	CbGeAlD
Perphenazine—HTR7—brain—Alzheimer's disease	0.000165	0.00322	CbGeAlD
Perphenazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000165	0.0018	CcSEcCtD
Perphenazine—Zuclopenthixol—HTR6—Alzheimer's disease	0.000163	0.0436	CrCbGaD
Perphenazine—HRH1—nervous system—Alzheimer's disease	0.000162	0.00314	CbGeAlD
Perphenazine—Diarrhoea—Donepezil—Alzheimer's disease	0.000161	0.00175	CcSEcCtD
Perphenazine—CYP2B6—central nervous system—Alzheimer's disease	0.000159	0.0031	CbGeAlD
Perphenazine—ADRA2A—nervous system—Alzheimer's disease	0.000159	0.00309	CbGeAlD
Perphenazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000157	0.00171	CcSEcCtD
Perphenazine—DRD2—brain—Alzheimer's disease	0.000156	0.00304	CbGeAlD
Perphenazine—Dizziness—Donepezil—Alzheimer's disease	0.000156	0.00169	CcSEcCtD
Perphenazine—HRH1—central nervous system—Alzheimer's disease	0.000156	0.00303	CbGeAlD
Perphenazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000154	0.00168	CcSEcCtD
Perphenazine—ADRA2A—central nervous system—Alzheimer's disease	0.000153	0.00297	CbGeAlD
Perphenazine—Pruritus—Memantine—Alzheimer's disease	0.000151	0.00164	CcSEcCtD
Perphenazine—Aripiprazole—HTR6—Alzheimer's disease	0.000151	0.0403	CrCbGaD
Perphenazine—ADRA2A—cerebellum—Alzheimer's disease	0.000149	0.0029	CbGeAlD
Perphenazine—Pruritus—Rivastigmine—Alzheimer's disease	0.000148	0.00161	CcSEcCtD
Perphenazine—Headache—Donepezil—Alzheimer's disease	0.000147	0.0016	CcSEcCtD
Perphenazine—Diarrhoea—Memantine—Alzheimer's disease	0.000146	0.00159	CcSEcCtD
Perphenazine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000143	0.00156	CcSEcCtD
Perphenazine—Dizziness—Memantine—Alzheimer's disease	0.000141	0.00154	CcSEcCtD
Perphenazine—CYP2C8—brain—Alzheimer's disease	0.000141	0.00274	CbGeAlD
Perphenazine—Thiothixene—HTR6—Alzheimer's disease	0.000141	0.0376	CrCbGaD
Perphenazine—Mesoridazine—HTR6—Alzheimer's disease	0.000139	0.0371	CrCbGaD
Perphenazine—Dizziness—Rivastigmine—Alzheimer's disease	0.000138	0.0015	CcSEcCtD
Perphenazine—HTR2A—nervous system—Alzheimer's disease	0.000135	0.00262	CbGeAlD
Perphenazine—Fluphenazine—CALM1—Alzheimer's disease	0.000135	0.036	CrCbGaD
Perphenazine—Headache—Memantine—Alzheimer's disease	0.000134	0.00146	CcSEcCtD
Perphenazine—Headache—Rivastigmine—Alzheimer's disease	0.000131	0.00142	CcSEcCtD
Perphenazine—HTR2A—central nervous system—Alzheimer's disease	0.00013	0.00253	CbGeAlD
Perphenazine—HTR2A—cerebellum—Alzheimer's disease	0.000127	0.00247	CbGeAlD
Perphenazine—CYP2B6—brain—Alzheimer's disease	0.000126	0.00246	CbGeAlD
Perphenazine—CYP3A4—nervous system—Alzheimer's disease	0.000125	0.00243	CbGeAlD
Perphenazine—HRH1—brain—Alzheimer's disease	0.000124	0.0024	CbGeAlD
Perphenazine—CYP2D6—nervous system—Alzheimer's disease	0.000123	0.00239	CbGeAlD
Perphenazine—Fluphenazine—HTR6—Alzheimer's disease	0.000122	0.0325	CrCbGaD
Perphenazine—ADRA2A—brain—Alzheimer's disease	0.000121	0.00236	CbGeAlD
Perphenazine—CYP3A4—central nervous system—Alzheimer's disease	0.00012	0.00234	CbGeAlD
Perphenazine—CYP2D6—central nervous system—Alzheimer's disease	0.000118	0.0023	CbGeAlD
Perphenazine—CYP2D6—cerebellum—Alzheimer's disease	0.000116	0.00225	CbGeAlD
Perphenazine—Clomipramine—HTR6—Alzheimer's disease	0.000111	0.0297	CrCbGaD
Perphenazine—Chlorprothixene—HTR6—Alzheimer's disease	0.000111	0.0296	CrCbGaD
Perphenazine—Promethazine—CALM1—Alzheimer's disease	0.000109	0.0292	CrCbGaD
Perphenazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000108	0.0288	CrCbGaD
Perphenazine—Thioridazine—HTR6—Alzheimer's disease	0.000105	0.028	CrCbGaD
Perphenazine—HTR2A—brain—Alzheimer's disease	0.000103	0.00201	CbGeAlD
Perphenazine—Trifluoperazine—HTR6—Alzheimer's disease	9.73e-05	0.026	CrCbGaD
Perphenazine—Ethopropazine—BCHE—Alzheimer's disease	9.47e-05	0.0253	CrCbGaD
Perphenazine—Quetiapine—HTR6—Alzheimer's disease	9.44e-05	0.0252	CrCbGaD
Perphenazine—CYP2D6—brain—Alzheimer's disease	9.4e-05	0.00183	CbGeAlD
Perphenazine—Flupentixol—HTR2A—Alzheimer's disease	8.55e-05	0.0228	CrCbGaD
Perphenazine—Chlorpromazine—CALM1—Alzheimer's disease	8.46e-05	0.0226	CrCbGaD
Perphenazine—Hydroxyzine—CYP2D6—Alzheimer's disease	8.16e-05	0.0218	CrCbGaD
Perphenazine—Triflupromazine—BCHE—Alzheimer's disease	7.76e-05	0.0207	CrCbGaD
Perphenazine—Chlorpromazine—HTR6—Alzheimer's disease	7.63e-05	0.0204	CrCbGaD
Perphenazine—Cyamemazine—HTR2A—Alzheimer's disease	6.7e-05	0.0179	CrCbGaD
Perphenazine—Nefazodone—SLC6A4—Alzheimer's disease	6.22e-05	0.0166	CrCbGaD
Perphenazine—Aripiprazole—SLC6A4—Alzheimer's disease	5.78e-05	0.0154	CrCbGaD
Perphenazine—Trazodone—SLC6A4—Alzheimer's disease	5.75e-05	0.0153	CrCbGaD
Perphenazine—Mequitazine—CYP2D6—Alzheimer's disease	5.33e-05	0.0142	CrCbGaD
Perphenazine—Domperidone—CYP2D6—Alzheimer's disease	5.26e-05	0.014	CrCbGaD
Perphenazine—Zuclopenthixol—HTR2A—Alzheimer's disease	4.81e-05	0.0128	CrCbGaD
Perphenazine—Nefazodone—HTR2A—Alzheimer's disease	4.78e-05	0.0127	CrCbGaD
Perphenazine—Aripiprazole—HTR2A—Alzheimer's disease	4.44e-05	0.0119	CrCbGaD
Perphenazine—Trazodone—HTR2A—Alzheimer's disease	4.42e-05	0.0118	CrCbGaD
Perphenazine—Zuclopenthixol—CYP2D6—Alzheimer's disease	4.39e-05	0.0117	CrCbGaD
Perphenazine—Nefazodone—CYP2D6—Alzheimer's disease	4.37e-05	0.0117	CrCbGaD
Perphenazine—Acepromazine—HTR2A—Alzheimer's disease	4.31e-05	0.0115	CrCbGaD
Perphenazine—Clomipramine—SLC6A4—Alzheimer's disease	4.26e-05	0.0114	CrCbGaD
Perphenazine—Thioproperazine—HTR2A—Alzheimer's disease	4.21e-05	0.0112	CrCbGaD
Perphenazine—Pipotiazine—HTR2A—Alzheimer's disease	4.14e-05	0.0111	CrCbGaD
Perphenazine—Thiothixene—HTR2A—Alzheimer's disease	4.14e-05	0.0111	CrCbGaD
Perphenazine—Mesoridazine—HTR2A—Alzheimer's disease	4.09e-05	0.0109	CrCbGaD
Perphenazine—Aripiprazole—CYP2D6—Alzheimer's disease	4.06e-05	0.0108	CrCbGaD
Perphenazine—Trazodone—CYP2D6—Alzheimer's disease	4.04e-05	0.0108	CrCbGaD
Perphenazine—Thiothixene—CYP2D6—Alzheimer's disease	3.79e-05	0.0101	CrCbGaD
Perphenazine—Pipotiazine—CYP2D6—Alzheimer's disease	3.79e-05	0.0101	CrCbGaD
Perphenazine—Chlorpromazine—BCHE—Alzheimer's disease	3.74e-05	0.00999	CrCbGaD
Perphenazine—Mesoridazine—CYP2D6—Alzheimer's disease	3.74e-05	0.00998	CrCbGaD
Perphenazine—Prochlorperazine—CYP2D6—Alzheimer's disease	3.62e-05	0.00966	CrCbGaD
Perphenazine—Fluphenazine—HTR2A—Alzheimer's disease	3.58e-05	0.00955	CrCbGaD
Perphenazine—Propiomazine—HTR2A—Alzheimer's disease	3.44e-05	0.00919	CrCbGaD
Perphenazine—Clomipramine—HTR2A—Alzheimer's disease	3.27e-05	0.00874	CrCbGaD
Perphenazine—Fluphenazine—CYP2D6—Alzheimer's disease	3.27e-05	0.00874	CrCbGaD
Perphenazine—Chlorprothixene—HTR2A—Alzheimer's disease	3.26e-05	0.0087	CrCbGaD
Perphenazine—Thioridazine—HTR2A—Alzheimer's disease	3.08e-05	0.00823	CrCbGaD
Perphenazine—Clomipramine—CYP2D6—Alzheimer's disease	2.99e-05	0.00799	CrCbGaD
Perphenazine—Methotrimeprazine—HTR2A—Alzheimer's disease	2.94e-05	0.00786	CrCbGaD
Perphenazine—Promethazine—HTR2A—Alzheimer's disease	2.9e-05	0.00774	CrCbGaD
Perphenazine—Trifluoperazine—HTR2A—Alzheimer's disease	2.86e-05	0.00764	CrCbGaD
Perphenazine—Thioridazine—CYP2D6—Alzheimer's disease	2.82e-05	0.00753	CrCbGaD
Perphenazine—Quetiapine—HTR2A—Alzheimer's disease	2.78e-05	0.00741	CrCbGaD
Perphenazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	2.69e-05	0.00719	CrCbGaD
Perphenazine—Promethazine—CYP2D6—Alzheimer's disease	2.65e-05	0.00708	CrCbGaD
Perphenazine—Promazine—HTR2A—Alzheimer's disease	2.55e-05	0.00681	CrCbGaD
Perphenazine—Quetiapine—CYP2D6—Alzheimer's disease	2.54e-05	0.00677	CrCbGaD
Perphenazine—Chlorpromazine—HTR2A—Alzheimer's disease	2.25e-05	0.00599	CrCbGaD
Perphenazine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.05e-05	0.00548	CrCbGaD
Perphenazine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.72e-06	1.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—Alzheimer's disease	1.71e-06	1.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CALM1—Alzheimer's disease	1.7e-06	1.78e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—LEP—Alzheimer's disease	1.69e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—APOE—Alzheimer's disease	1.69e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—APOE—Alzheimer's disease	1.69e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—LEP—Alzheimer's disease	1.69e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CAV1—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CAV1—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ESR1—Alzheimer's disease	1.67e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1B—Alzheimer's disease	1.67e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1B—Alzheimer's disease	1.67e-06	1.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.66e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.66e-06	1.73e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—Alzheimer's disease	1.66e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—Alzheimer's disease	1.66e-06	1.73e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.66e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.65e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—F2—Alzheimer's disease	1.65e-06	1.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.65e-06	1.72e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.64e-06	1.71e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	1.71e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	1.71e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.63e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.63e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.63e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ESR1—Alzheimer's disease	1.62e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ESR1—Alzheimer's disease	1.62e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.62e-06	1.69e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.61e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.61e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.61e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.61e-06	1.68e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.61e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—AKT1—Alzheimer's disease	1.6e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—F2—Alzheimer's disease	1.6e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—F2—Alzheimer's disease	1.6e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.59e-06	1.66e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	1.59e-06	1.66e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.59e-06	1.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK8—Alzheimer's disease	1.58e-06	1.65e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	1.65e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	1.65e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—NOS3—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.56e-06	1.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.56e-06	1.63e-05	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.56e-06	1.63e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—INS—Alzheimer's disease	1.56e-06	1.63e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.55e-06	1.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—AKT1—Alzheimer's disease	1.55e-06	1.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—AKT1—Alzheimer's disease	1.55e-06	1.62e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.55e-06	1.61e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.54e-06	1.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—AKT1—Alzheimer's disease	1.54e-06	1.61e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.54e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.53e-06	1.6e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.53e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK8—Alzheimer's disease	1.53e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK8—Alzheimer's disease	1.53e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—NOS3—Alzheimer's disease	1.52e-06	1.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—NOS3—Alzheimer's disease	1.52e-06	1.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.52e-06	1.58e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.51e-06	1.58e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—AKT1—Alzheimer's disease	1.51e-06	1.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CREB1—Alzheimer's disease	1.51e-06	1.57e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.5e-06	1.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—INS—Alzheimer's disease	1.5e-06	1.56e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.5e-06	1.56e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.49e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—Alzheimer's disease	1.49e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—Alzheimer's disease	1.49e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.49e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.48e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.48e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.48e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—Alzheimer's disease	1.47e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.47e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.47e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.47e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CREB1—Alzheimer's disease	1.46e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CREB1—Alzheimer's disease	1.46e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—INS—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—INS—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.44e-06	1.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—Alzheimer's disease	1.44e-06	1.5e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—Alzheimer's disease	1.42e-06	1.49e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—Alzheimer's disease	1.42e-06	1.49e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.42e-06	1.49e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.42e-06	1.48e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.42e-06	1.48e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.42e-06	1.48e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1—Alzheimer's disease	1.4e-06	1.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1—Alzheimer's disease	1.4e-06	1.46e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.39e-06	1.45e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—Alzheimer's disease	1.39e-06	1.45e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—Alzheimer's disease	1.39e-06	1.45e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.44e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.37e-06	1.43e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.36e-06	1.42e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.42e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-06	1.41e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-06	1.41e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.35e-06	1.41e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1.39e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1.39e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.32e-06	1.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—Alzheimer's disease	1.31e-06	1.37e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.31e-06	1.37e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.3e-06	1.36e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.29e-06	1.35e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.28e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.28e-06	1.33e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.28e-06	1.33e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.27e-06	1.33e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—Alzheimer's disease	1.27e-06	1.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—Alzheimer's disease	1.27e-06	1.33e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.27e-06	1.32e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.27e-06	1.32e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.26e-06	1.31e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-06	1.31e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.31e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.25e-06	1.3e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—Alzheimer's disease	1.24e-06	1.29e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	1.29e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.23e-06	1.29e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	1.29e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	1.29e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	1.29e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	1.28e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	1.28e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.22e-06	1.28e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.22e-06	1.27e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.21e-06	1.27e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.21e-06	1.26e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.2e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—Alzheimer's disease	1.2e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—Alzheimer's disease	1.2e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.17e-06	1.22e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	1.21e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.21e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	1.19e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	1.19e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.14e-06	1.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.14e-06	1.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.12e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.12e-06	1.17e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.12e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.08e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—Alzheimer's disease	1.08e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—Alzheimer's disease	1.08e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—Alzheimer's disease	1.07e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—Alzheimer's disease	1.07e-06	1.12e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-06	1.11e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.06e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.05e-06	1.1e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	1.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	1.09e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.04e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.03e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.02e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.02e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.02e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—Alzheimer's disease	1.01e-06	1.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	9.96e-07	1.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	9.91e-07	1.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK8—Alzheimer's disease	9.91e-07	1.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK8—Alzheimer's disease	9.91e-07	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—Alzheimer's disease	9.88e-07	1.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—Alzheimer's disease	9.88e-07	1.03e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.82e-07	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—Alzheimer's disease	9.78e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—Alzheimer's disease	9.78e-07	1.02e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	9.78e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.78e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.69e-07	1.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	9.51e-07	9.93e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	9.5e-07	9.92e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—Alzheimer's disease	9.46e-07	9.87e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—Alzheimer's disease	9.34e-07	9.75e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—Alzheimer's disease	9.33e-07	9.75e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—Alzheimer's disease	9.15e-07	9.55e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—Alzheimer's disease	9.15e-07	9.55e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.12e-07	9.52e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.07e-07	9.47e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—Alzheimer's disease	9.03e-07	9.43e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—Alzheimer's disease	9.03e-07	9.43e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—Alzheimer's disease	9.03e-07	9.43e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—Alzheimer's disease	9.03e-07	9.43e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	8.75e-07	9.14e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.69e-07	9.07e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—Alzheimer's disease	8.68e-07	9.06e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—Alzheimer's disease	8.62e-07	9e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	8.61e-07	8.99e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	8.59e-07	8.97e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.52e-07	8.9e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.41e-07	8.79e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—Alzheimer's disease	8.4e-07	8.77e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—Alzheimer's disease	8.4e-07	8.77e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	8.37e-07	8.74e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—INS—Alzheimer's disease	8.36e-07	8.73e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—Alzheimer's disease	8.33e-07	8.7e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—Alzheimer's disease	8.33e-07	8.7e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.01e-07	8.36e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	7.91e-07	8.26e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	7.88e-07	8.23e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	7.86e-07	8.21e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	7.83e-07	8.18e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	7.41e-07	7.74e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.39e-07	7.71e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.33e-07	7.65e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.27e-07	7.59e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.25e-07	7.57e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—Alzheimer's disease	7.22e-07	7.54e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	7.17e-07	7.49e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—Alzheimer's disease	7.14e-07	7.46e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—Alzheimer's disease	6.98e-07	7.29e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—Alzheimer's disease	6.98e-07	7.29e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—Alzheimer's disease	6.91e-07	7.22e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—Alzheimer's disease	6.91e-07	7.22e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.7e-07	7e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	6.61e-07	6.91e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—Alzheimer's disease	6.54e-07	6.83e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—Alzheimer's disease	6.33e-07	6.61e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—Alzheimer's disease	6.33e-07	6.61e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	6.28e-07	6.55e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—Alzheimer's disease	6.03e-07	6.3e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—Alzheimer's disease	5.84e-07	6.09e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—Alzheimer's disease	5.84e-07	6.09e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	5.6e-07	5.85e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.15e-07	5.38e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.11e-07	5.33e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.37e-07	4.56e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.37e-07	3.52e-06	CbGpPWpGaD
